Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries

• Main Authors: Szczepan Jakubowski (Author), Przemysław Holko (Author), Rafał Nowak (Author), Marisa Warmuth (Author), Marc Dooms (Author), Outi Salminen (Author), Lucas Cortial (Author), Gisbert W. Selke (Author), Christina Georgi (Author), Einar Magnússon (Author), Salvatore Crisafulli (Author), Fons Strijbosch (Author), Tanja Mueller (Author), Eleanor Grieve (Author), Immaculada Danés (Author), Paweł Kawalec (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

ObjectivesThe aim of the study was to assess the reimbursement policy for orphan drugs (ODs) in selected European countries in relation to the availability and impact of clinical evidence, health technology assessment (HTA) procedures and reimbursement decision-making.Materials and MethodsA list of...